Q2 and H1 FY27: revenue up 16%, EBITDA margin expands

Investor Communications View source PDF Explain this filing

METROPOLIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹570.75

prior close

₹579.00

announcement price

After-mkt

timing

Nifty Microcap 250market+2.2%-0.6% vs market

Healthcare Service Provider peers, median of 27sector+2.0%-0.4% vs sector

On the reaction day the stock moved 0.6 pts less than Nifty Microcap 250 and 0.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.8

10m

-5.1

15m

-4.5

30m

-4.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6+2.2-0.6+2.0-0.4

Next day

+0.6+3.3-2.7+1.1-0.5

+0.1pendingpending+0.0+0.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Metropolis posted Q2 FY27 revenue of INR 496.8 crore, up 15.8% year on year, EBITDA of INR 134.9 crore and PAT of INR 75.5 crore. EBITDA margin rose 180 basis points to 27.2%. In H1, revenue was INR 947 crore, up 16.2%, PAT rose 34.9% to INR 132.4 crore, and EBITDA margin improved 190 basis points to 26.2%. Growth was volume-led, with no price increase.

Likely market impact

Positive: volume-led revenue growth and faster profit growth show operating leverage, supporting earnings sentiment, though the filing gives no new financial guidance.